Syntactx, Now Part of NAMSA

Syntactx is a leading, full-service CRO with deep expertise in complex, interventional medical device and drug trials. Led by key thought leaders who understand first-hand whats at stake, clients count on us to synthesize the clinical evidence behind their innovative products for market approvals and broad market adoption. We provide solutions for: Market Leaders Emerging Companies Early-Stage Startups Physicians and Institutions Having long careers in clinical practice and academia, our world-renowned physicians were national principal investigators on multiple, landmark clinical trials for medicines most advanced technologies. They work in tandem with the companys team of clinical and regulatory professionals who...

Medical writing,site monitoring,electronic data capture,sas programming,safety,cec and dsmb oversight,data analysis and statistics,site selection,contracting,and management,pharmaceuticals,bimo audit,clinical evaluation reports,imaging core laboratory,fda panel prep,medical and combination devices,regulatory submissions,pma submissions,trial design,global regulatory strategy,post market studies,and investigator-initiated research

Syntactx, now part of namsa operates in the Research services industry.

Syntactx, now part of namsa's revenue is 11m - 100m

Syntactx, now part of namsa has 11 - 50 employees.